ReviewHeart failure reviews2026
The spectrum of congestion in heart failure: underlying pathophysiology and diagnostic strategies.
Review in Heart failure reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Congestion is the main driver of heart failure (HF) recurrence and its relief remains the primary therapeutic target during acute management. In most studies achievement of decongestion is evaluated by clinical examination. The lack of accurately recognizing congestion, together with the incomplete understanding of its underlying pathophysiological mechanisms, may lead to a substantial discordance between de-congestion and mortality risk reduction. To avoid these concerns, a classification dividing congestion between intra vs. extravascular, has been recently purposed but it is still based on clinical signs rather than an integrated diagnostic assessment. Additionally, across several studies, congestion is evaluated at various time moments and with different diagnostic methods. Over the last decades new approaches combining ultrasonographic evaluation, invasive measurement and biomarkers have been suggested, although a universal multi-parametric diagnostic strategy is not extensively applied. The complex mechanisms and dynamic nature of fluid retention, venous capacitance, lymphatic conditions and interstitial space integrity are relevant components which contributes to create further misunderstanding. The numerous cardiac and extracardiac factors potentially involved in congestion onset and recurrence need to be addressed during the evaluation. In this paper we would gather potential approaches for early congestion detection according to HF profile, based on the assumption that hemodynamic congestion and increased cardiac pressure does not necessarily coincide with systemic fluid retention.
Indexed as
Identifiers
42184091What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.